Beyond Air, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beyond Air, Inc. on June 27, 2024, covering events occurring on June 21, 2024. The filing primarily details a material amendment to the Company's existing loan agreement and the issuance of warrants to lenders.
Key Financial Metrics and Debt Structure
The filing does not provide specific revenue, profit, or cash flow figures for the current period, as it references a separate press release for Q4 and fiscal year 2024 results. However, it outlines the following debt and liquidity terms:
- Total Loan Facility: Up to $40.0 million in senior secured term loans.
- Tranche 1: $17.5 million advanced on June 15, 2023.
- Tranche 2: Up to $10.0 million available between April 1, 2024, and September 30, 2024, contingent on achieving 85% of projected product revenue for the prior three-month period.
- Discretionary Tranche: Up to $12.5 million available after April 1, 2024, subject to lender approval and mutual agreement.
- Interest Rate: The greater of (i) Prime Rate + 3.75% or (ii) 12.00% per annum.
- Maturity Date: June 1, 2027.
- Amendment Fees: $87,500 paid immediately, with an additional $87,500 due upon maturity or prepayment.
Material Changes Versus Prior Period
The primary material change is the extension of the interest-only period under the Loan Agreement:
- Previous Terms: Interest-only period ended December 15, 2024, with amortization commencing January 1, 2025.
- New Terms: Interest-only period extended to June 30, 2025, with amortization commencing July 1, 2025.
- Further Deferral Option: Principal payments may be deferred an additional 12 months if the Company achieves at least $40.0 million in product revenue for the fiscal year ending March 31, 2025, and has fully drawn Tranche 2.
Guidance, Outlook, and Unusual Items
Warrant Issuance: In connection with the amendment, the Company issued warrants to the lenders (Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P.) to purchase a total of 100,000 shares of common stock.
- Exercise Price: $1.28 per share.
- Expiration Date: June 30, 2029.
- Terms: Warrants may be exercised for cash or on a cashless basis and include anti-dilution adjustments.
- Registration: The Company intends to file a registration statement for the resale of these shares within 60 days.
Financial Results Reference: The filing notes that financial results for the fourth fiscal quarter and year ended March 31, 2024, were announced via press release on June 24, 2024, but specific numbers are not included in this text.
Key Facts for Investor Verification
- Verify the Company's current product revenue status to determine eligibility for the $10.0 million Tranche 2 funding.
- Confirm the Company's progress toward the $40.0 million product revenue target required for the potential 12-month further deferral of principal payments.
- Review the June 24, 2024 press release (Exhibit 99.1) for actual Q4 and fiscal year 2024 financial performance metrics.
- Monitor the filing of the registration statement for the 100,000 warrant shares to ensure liquidity for the lenders.
- Assess the impact of the extended interest-only period on the Company's near-term cash flow requirements.